Innovative Pharmaceutical Biotech Limited has announced the issuance of new shares under a general mandate. The company, which is listed on the Main Board of the Stock Exchange, is set to issue up to 344,638,604 shares, representing about 20% of its current share capital. This decision follows the approval of the general mandate at the company's annual general meeting. The subscription involves 137,600,000 shares priced at HK$0.176 per share. Investors are advised to exercise caution when dealing with the company's securities.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.